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Abstract
Background: In this study we set out to investigate the clinically observed relationship between chronic obstructive
pulmonary disease (COPD) and aortic aneurysms. We tested the hypothesis that an inherited deficiency of connective tissue
might play a role in the combined development of pulmonary emphysema and vascular disease.
Methods: We first determined the prevalence of chronic obstructive pulmonary disease in a clinical cohort of aortic
aneurysms patients and arterial occlusive disease patients. Subsequently, we used a combined approach comprising
pathological, functional, molecular imaging, immunological and gene expression analysis to reveal the sequence of events
that culminates in pulmonary emphysema in aneurysmal Fibulin-4 deficient (Fibulin-4R) mice.
Results: Here we show that COPD is significantly more prevalent in aneurysm patients compared to arterial occlusive
disease patients, independent of smoking, other clinical risk factors and inflammation. In addition, we demonstrate that
aneurysmal Fibulin-4R/R mice display severe developmental lung emphysema, whereas Fibulin-4+/R mice acquire alveolar
breakdown with age and upon infectious stress. This vicious circle is further exacerbated by the diminished antiprotease
capacity of the lungs and ultimately results in the development of pulmonary emphysema.
Conclusions: Our experimental data identify genetic susceptibility to extracellular matrix degradation and secondary
inflammation as the common mechanisms in both COPD and aneurysm formation.
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Introduction
Chronic obstructive pulmonary disease (COPD) is worldwide
one of the major causes of morbidity and mortality [1]. In addition
to chronic airflow obstruction due to airway inflammation and
alveolar destruction, COPD is associated with extrapulmonary
manifestations, including cardiovascular diseases [2–5]. These
comorbid conditions contribute to the overall disability of patients
and complicate the management of COPD.
Aortic aneurysm (AA) is one of the cardiovascular diseases
related to COPD [6,7]. The nature of this relationship is currently
unknown. Patients with COPD, AA, and/or atherosclerosis share
a number of risk factors, including age, hypertension, and tobacco
smoking [8,9]. Resemblances in risk profiles between these
conditions, most notably smoking, may account for the relation
between AA and COPD. Furthermore, a systemic inflammatory
response has been suggested as a common denominator [10].
The association between COPD and AA prompted us to
investigate the prevalence of COPD in a large cohort of patients
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with aneurysmal or arterial occlusive disease (AOD) in relation to
their clinical risk profiles. Here, we found that COPD is much
more prevalent in patients with AA compared to those with AOD,
irrespective of common clinical risk factors. Since AA [11,12] and
COPD [13] are associated with destruction of the extracellular
matrix (ECM), we hypothesized that a primary ECM defect may
provide a common ground for the combined development of
COPD and aneurysm formation. We previously demonstrated
that mice with reduced expression of the ECM glycoprotein
Fibulin-4 exhibit ECM degradation in the aortic wall and AA
formation [14,15]. We here investigated the role of Fibulin-4
deficiency in the development of lung emphysema.
Results
Clinical study
Patient characteristics. We included 1393 patients; 614
patients (44%) were diagnosed with AA and 779 patients (56%)
with AOD. The majority of AA patients were treated for an
abdominal aortic aneurysm (AAA). None of the patients in this
series were treated for an aneurysm of the ascending aorta; 62/614
(10%) of patients were treated for an aneurysm of the descending
thoracic aorta (TAA). Clinical characteristics of AA and AOD
patients are presented in Table 1. Patients with AA were on
average older and more frequently of male gender. Patients with
AOD had higher rates of diabetes, hypercholesterolemia, and
cerebrovascular disease. In addition, there were differences in
medication use between the two groups: statins and antiplatelet
drugs were more commonly used by patients with AOD, whereas
beta-blockers were more often used by patients with AA.
Importantly, smoking rates were similar in the two patient groups.
A differentiation in clinical characteristics between AAA and TAA
patients is presented in Table S1.
Association between COPD and AA. COPD was more
common in AA patients as compared to AOD patients (42% vs.
26%, p,0.001, Figure 1A). COPD rates did not differ between
TAA and AAA patients (Table S2). Univariate logistic regression
analysis showed a significant association between COPD and AA
(odds ratio 2.08, 95%CI: 1.66–2.61, p,0.001; Table S3). Since
patients with COPD, AA, and AOD shared a number of
cardiovascular risk factors, we subsequently performed a multi-
variable regression analysis. Even after adjustment for potentially
confounding factors the association between COPD and AA
remained significant (odds ratio 1.56, 95%CI: 1.16–2.10,
p = 0.003; Table S3).
As inflammation is involved in aneurysm development, athero-
sclerosis, and COPD, we measured serum levels of the systemic
inflammatory biomarker high-sensitivity C-reactive protein (hs-
CRP). The median serum hs-CRP concentration was higher in
patients with AA compared to AOD (5.9 [IQR 2.9–12.5] vs
4.8 mg/L [IQR 2.1–11.1], p = 0.02). However, there were no
differences in hs-CRP levels between arterial disease patients with
COPD and those without COPD (median 5.4 vs 5.2 mg/L,
p= 0.776; Figure 1B). These data strongly support the association
between AA and COPD in patients independently of smoking and
other cardiovascular risk factors.
Experimental study
Extracellular matrix remodeling in aortas of Fibulin-4
deficient mice. Complete disruption of Fibulin-4 is incompat-
ible with life as targeted disruption of Fibulin-4 abolishes
elastogenesis and causes perinatal lethality in mice [16]. We
previously generated a viable mouse model for Fibulin-4 using a
hypomorphic Fibulin-4 allele (Fibulin4R) which results in reduced
expression by transcriptional interference through placement of a
TKneo targeting construct in a downstream gene (Mus81)[14].
While Mus81 knockout mice, from which the selectable marker
was removed, were born at expected Mendelian frequencies and
were indistinguishable from wild type littermates in terms of
development, growth, immune function and fertility [17], our
Fibulin-4 hypomorphic mice displayed a 2-fold lower expression of
Fibulin-4 in heterozygous Fibulin-4+/R aortas and a 4-fold
downregulation in homozygous Fibulin-4R/R aortas, resulting in
ECM defects and vascular abnormalities, including aortic
aneurysms in the aorta ascendens [14]. Indeed, comparison of
haematoxylin-eosin (HE) and elastin stained aortas of 3-month old
Fibulin-4+/+, Fibulin-4+/R and Fibulin-4R/R mice showed severe
thickening and decellularization of the medial layer of the
ascending aortic wall in Fibulin-4R/R mice and fragmented and
disorganized elastin laminae resulting in 2–3 fold dilated ascending
aortic aneurysms in all homozygous knockdown animals analyzed
(Figure 2A). While Fibulin-4+/R aortas are not dilated, careful
histological comparison showed an increased medial thickness,
signs of elastin breakage and increased deposition of amorphous
cell material between the elastin layers compared to wild type
animals (Figure 2A). The downregulation of Fibulin-4 leads to
elastin abnormalities in the ascending aorta accompanied by
extensive remodeling of the ECM presumably through activation
of matrixmetalloproteinases (MMPs). The increased activity of
MMPs can be visualized with an MMP-specific activatable near-
infrared (NIRF) probe developed for in vivo imaging (Perkin
Elmer). Fibulin-4+/R and Fibulin-4R/R mice injected with this
protease sensing probe show a gradual increase in NIRF signal in
the thoracic area, indicative of aneurysm formation [14,15]. Here,
we injected this MMP activatable NIRF probe and sacrificed the
mice after 24 hrs after which the hearts with aortas were excised.
When we compared the ex vivo fluorescence in the aortic arch and
descending aorta using the Odyssey imaging system, we measured
a gradual increase of MMP activation in Fibulin-4+/R and Fibulin-
4R/R compared to wild type Fibulin-4+/+ mice (Figure 2B, upper
row). Since this was consistent with the gradual elastin degradation
we noticed histologically, we then used these protease sensing
probes to analyze the abdominal part of the aorta, below the
diaphragm. Ex-vivo analysis confirmed the in vivo observed
gradual increase in MMPs within the aneurysmal lesions in the
thoracic aorta (Th) and showed as well a gradual increased activity
in the abdominal aorta (Ab) in both Fibulin-4+/R and Fibulin-4R/R
mice. Thus, decreased expression of fibulin-4 not only leads to
MMP activation in the thoracic part of the aorta, but equally
affects the abdominal aorta, predisposing the complete aorta for
arterial disease. Since we find extracellular matrix remodeling
activity in both thoracic and abdominal aorta, we conclude that
the Fibulin-4+/R and Fibulin-4R/R mouse models mimics different
stages of both TAA and AAA.
Alveolar airspace enlargement in Fibulin-4 deficient
mice. In the clinical study, we observed a significant association
between COPD and AA. To investigate whether ECM abnor-
malities may provide a common ground for aneurysm formation
and COPD we subsequently analyzed whether fibulin-4 deficiency
also predisposes for lung abnormalities in these Fibulin-4
hypomorfic mice.
To this end, we first tested whether the transcriptional
downregulation of Fibulin-4 also occurs in the lungs of these
mutant mice. Expression levels of Fibulin-4 mRNA in newborn
and adult lungs of Fibulin-4+/R and Fibulin-4R/R mice were
indeed significantly lower compared to Fibulin-4+/+ mice (Fig-
ure 3A). Next, we examined whether Fibulin-4 animals display
lung emphysema. Assessment of respiratory performance by
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whole-body plethysmography showed similar breathing frequen-
cies and Peak Inspiratory Flows (PIF) in adult Fibulin-4 deficient
mice and Fibulin-4+/+ littermates, whereas the Peak Expiratory
Flow (PEF) tended to decrease over time in Fibulin-4R/R mice
(Figure 3B). Significance could not be determined since 2 out of 4
Fibulin-4R/R mice died during the course of the experiment.
Downregulation of Fibulin-4 was accompanied by alveolar
airspace enlargement in adult Fibulin-4+/R and Fibulin-4R/R lungs
(Figure 3C). In newborn mice, reduced pulmonary Fibulin-4
expression levels coincided with clear alveolar airspace enlarge-
ments in Fibulin-4R/R lungs, but not in Fibulin-4+/R lungs
(Figures 3C and 3D, and accompanying Figure S1A and B).
Importantly, analysis of the aortas of the adult mice used for lung
analysis showed a gradual thickening of the medial layers of the
aorta (Figure S1C). Elastin staining showed sites of complete
fragmentation and disarray of the elastin layers in Fibulin-4R/R
aortas and increased deposition of amorphous material between
the elastin layers in Fibulin-4+/R animals (Figure S1D), indicating
that a similar gene-doses decrease in Fibulin-4 expression affects
both lungs and the aortic wall in these mice. Immunohistochem-
istry on lung tissue with antibodies specific for certain lung cell
markers, including thyroid transcription factor 1 (TTF-1), Clara-
cell-specific protein (CC-10), and a-smooth muscle actin (a-SMA)
demonstrated no differences in the presence and relative
distribution of the major cell types in the lungs of Fibulin-4+/R
and Fibulin-4R/R mice (Figure S2), which may exclude altered
airway-cell differentiation.
These results show that in addition to aortic abnormalities, a
decrease in Fibulin-4 expression leads to gene dose-dependent
alterations in the lung. While the emphysematous changes in the
lungs of newborn Fibulin-4R/R mice suggest a developmental
defect, Fibulin-4+/R mice acquired the COPD phenotype with
age.
Transcriptome analysis of Fibulin-4+/R and Fibulin-4R/R
lungs. In order to get an idea of the underlying processes
involved, we performed gene expression analysis on mRNA
isolated from Fibulin-4+/+, Fibulin-4+/R and Fibulin-4R/R lung
tissue, both newborn as well as adult. Comparison of RNA
expression between newborn Fibulin-4+/+, Fibulin-4+/R and
Fibulin-4R/R lungs with Significance Analysis of Microarrays
[18] revealed a limited set of differentially regulated genes.
Comparison of RNA expression between adult Fibulin-4+/+ and
Fibulin-4R/R lungs using SAM (FDR 10%) revealed 374
deregulated genes (both up- and downregulated), whereas no
deregulated genes were found between Fibulin-4+/+ and Fibulin-
4+/R lungs.
Of the 20 most significantly up-regulated genes in adult Fibulin-
4R/R lungs, 50% were involved in inflammation processes
(Table 2 and Table S4). Network analysis with Ingenuity pathway
analysis (IPA) on the 374 deregulated probes revealed many
significantly changed pathways involved in the immune system
(Table S5). This suggests that the severe airspace enlargement in
adult Fibulin-4R/R lungs coincides with overexpression of genes
involved in inflammatory processes.
Spontaneous inflammation in adult Fibulin-4R/R
lungs. To investigate whether indeed the immune system shows
significant alterations in the lungs of Fibulin-4R/R animals, we did
flow cytometric analysis of broncho-alveolar lavage (BAL) samples.
This analysis showed more inflammatory cells, in particular
granulocytes (Gr-1+) and B-cells (CD19+), in lungs of adult




Male gender (%) 525 (85.5) 521 (66.9) ,0.001
Age (years 6 SD) 71.467.8 65.6611.0 ,0.001
Body mass index (kg/m2, mean 6 SD) 26.163.9 26.264.3 0.540
Cardiovascular comorbidities (%)
Congestive heart failure 66 (10.7) 89 (11.4) 0.692
Ischemic heart disease 272 (44.3) 306 (39.3) 0.059
Cerebrovascular disease 89 (14.5) 366 (47.0) ,0.001
Cardiovascular risk factors (%)
Kidney disease 94 (15.3) 106 (13.6) 0.368
Diabetes mellitus 103 (16.8) 225 (28.9) ,0.001
Hypertension 408 (66.4) 524 (67.2) 0.761
Hypercholesterolemia 534 (87.0) 706 (90.6) 0.030
Smoking – current 236 (38.4) 338 (43.3) 0.068
Smoking – ever 473 (77.0) 613 (78.7) 0.459
Medication (%)
Statins 446 (72.6) 633 (81.2) ,0.001
Beta-blockers 531 (86.4) 592 (75.9) ,0.001
Renin-angiotensin system inhibitors 271 (44.1) 369 (47.3) 0.247
Diuretics 138 (22.4) 211 (27.0) 0.052
Antiplatelets 353 (57.4) 581 (74.5) ,0.001
doi:10.1371/journal.pone.0106054.t001
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Fibulin-4R/R compared to Fibulin-4+/+ and Fibulin-4+/R mice
(Figure 4A). Cell suspensions of Fibulin-4R/R lungs contained
significantly more macrophages (F4/80+) compared to Fibulin-4+/
+ and Fibulin-4+/R lungs (Figure 4B), and tended to contain more
T-cells (CD3+) and dendritic cells (CD11c+). Immunohistochem-
ical analysis showed focal infiltrations of inflammatory cells around
veins and bronchi in adult Fibulin-4R/R lungs (Figure 4C), mainly
consisting of T-cells and dendritic cells. Cytokine analysis of BAL
samples showed significantly higher levels of IL-1b in Fibulin-4R/R
but not in Fibulin-4+/R as compared to Fibulin-4+/+ mice
(Figure 4D) Interestingly, IL-1b is a pro-inflammatory cytokine
which is mainly produced by activated macrophages and which is
increased in patients with COPD [19,20]. These data indicate that
the severe airspace enlargement observed in lungs of adult Fibulin-
4R/R mice was accompanied by up-regulation of inflammatory
pathways, whereas the milder lung abnormalities in Fibulin-4+/R
animals were not associated with an explicit inflammation process.
Disturbed TGF-b signaling in Fibulin-4 deficient
lungs. Since degradation of the vascular wall in aortic
aneurysms is related to disturbances in the TGF-b signaling
pathway [14,21], we next investigated the role of TGF-b signaling
in alveolar wall degradation in Fibulin-4 deficient mice. Although
the gene expression analysis in lung mRNA samples only gave rise
to a limited set of deregulated genes in newborn Fibulin-4R/R
animals, it did reveal downregulation of the Pias4 gene in Fibulin-
4R/R compared to Fibulin-4+/+ lungs (1.2-fold, p,0.05, Table S6).
In adult Fibulin-4R/R lungs we identified up-regulation of TGF-b2
and downregulation of the type 2b activin A receptor. In adult
Fibulin-4+/R lungs the ‘SMAD specific E3 ubiquitin protein ligase
1’ (Smurf1) gene was significantly downregulated compared to
Fibulin-4+/+ lungs.
Figure 1. Prevalence and severity of COPD in patients with an
aortic aneurysm (AA) or arterial occlusive disease (AOD). (A)
The prevalence of COPD in all GOLD classes was higher in AA (n = 614)
compared to AOD patients (n = 779, ***p,0.001). (B) Serum high-
sensitivity CRP levels according to severity of COPD in patients with AA
or AOD. There was no significant difference between patients with and
without COPD (p for trend= 0.123).
doi:10.1371/journal.pone.0106054.g001
Figure 2. Degenerative arterial wall changes and increased
MMP activity in Fibulin-4 animals. (A) Comparison of the
architecture of the aortic wall in Fibulin-4+/+, Fibulin-4+/R, and Fibulin-
4R/R mice. Top: Haematoxylin- eosin (HE) staining of cross-sections from
120 day-old mice. Bottom: Aberrations in elastic laminae in Fibulin-4R/R
mice, consisting of a fragmented and disorganized appearance of
elastin in the medial layers of the aorta. In heterozygous Fibulin-4+/R
mice, interrupted elastin layers and areas in the aortic wall with a
granular appearance of elastic laminae are present, albeit milder,
indicating a gene dosage effect. Scale bar indicates 100 mm (B) Ex-vivo
analysis shows a gradual increase in active MMPs as detected with the
activatable NIRF probe MMPSense 680. Within the aneurysmal lesions in
the thoracic aorta (Th), as well as in the abdominal aorta (Ab) of Fibulin-
4+/R and Fibulin-4R/R mice, a graded increase in MMP activity is
detected.
doi:10.1371/journal.pone.0106054.g002
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Figure 3. Enlarged alveolar airspaces in lungs of Fibulin-4 knockdown mice. (A) Expression levels of Fibulin-4 in lungs isolated from
newborn (n = 4, n = 4, n = 3) and adult (n = 4, n = 4, n = 4) Fibulin-4+/+, Fibulin-4+/R and Fibulin-4R/R mice relative to Fibulin-4+/+ lungs (**p,0.01). (B)
Mean peak inspiratory flow (PIF) and peak expiratory flow (PEF) values for Fibulin-4+/+ (n = 4), Fibulin-4+/R (n = 4) and Fibulin-4R/R mice (observed for
n = 4, but two animals died during the procedure) at 3-minute intervals. After a 9 minute adaptation period (the first three time intervals), PIF follows
similar trends in Fibulin-4+/+, Fibulin-4+/R and Fibulin-4R/R mice, while Fibulin-4R/R mice show a decrease in PEF. (C) HE stained sections of formalin
fixed lungs of male mice. Enlarged alveolar airspaces are observed in Fibulin-4+/R (middle, n = 3) and Fibulin-4R/R lungs (right, n = 3), with the latter
being more pronounced, compared to Fibulin-4+/+ (n = 3). Enlarged alveolar airspaces are already present in Fibulin-4R/R newborn lungs (n = 3), while
lungs of Fibulin-4+/R littermates (n = 5) show no difference compared to Fibulin-4+/+ lungs (n = 4). Scale bar 100 mm. Magnification 10x. (D) D2
quantification (see methods and Figure S1 for further explanation) of the alveolar airspaces revealed a significant difference between adult Fibulin-4+/
+ and Fibulin-4+/R (*p,0.05) and between adult Fibulin-4+/+ and Fibulin-4R/R lungs (**p,0.01) as well as between newborn Fibulin-4+/+ and Fibulin-4R/
R lungs (*p,0.05).
doi:10.1371/journal.pone.0106054.g003
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To check at the protein level whether changes in the TGF-b
system occurred, we performed immunoblot analysis for phos-
phorylation of Smad2 (pSmad2), an intracellular mediator of the
TGF-b pathway. These blots showed a gradual increase in
pSmad2 in adult Fibulin-4 deficient lungs, indicating increased
TGF-b activity (Figure 5A). In Fibulin-4+/R lungs we observed a
1.32-fold change for pSmad2 relative to total Smad and a 1.23-
fold change relative to actin when compared to Fibulin-4+/+ lungs.
In Fibulin-4R/R lungs we observed a 1.67-fold and 1.5-fold
change, respectively (Figure 5A and data not shown). Accumula-
tion of phosphorylated smad2 is a general read out of activity for
the TGF-b signaling pathway. Smad4 binding to phosphorylated
Smad2 is necessary for translocation to the nucleus Subsequently
the smad2/3/4 complex can then bind to the DNA after which
transcription is initiated. We therefore also determined phosphor-
ylation of pSmad3 in protein extracts of the lungs of Fibulin-4+/+,
Fibulin-4+/R and Fibulin-4R/R mice and find a gradual increase of
pSmad3 in the mutant animals confirming the activation of the
central TGF-b transcription factor Smad2/3/4 (Figure 5B).
Immunohistochemistry confirmed increased pSmad2 expression
in Clara cells lining the bronchioles of the lungs as well as in
inflammatory cell infiltrates (Figure 5C). Together these data show
that TGF-b activity is mildly increased in adult Fibulin-4+/R and
Fibulin-4R/R lungs, which may contribute to the breakdown of
alveolar walls in adult Fibulin-4 deficient mice. This upregulation
of TGF-b signaling is reminiscent of the upregulation that has
been observed in the aortas of both mouse models of aortic
aneurysms as well as in patients [14,15,27].
Overlapping downregulation of SERPINA1 in lungs of
Fibulin-4 deficient mice and COPD patients. To investigate
a potential common underlying mechanism of the observed lung
emphysema phenotype in our Fibulin-4 animals and that in
COPD patients, we compared our mouse dataset to gene lists
related to COPD that we derived from IPA and gene expression
datasets from lung emphysema patients. A search in IPA with the
search term ‘chronic obstructive pulmonary disease’ gave 248
records, which we refer to as ‘COPD-related genes’. Next, gene
expression data from the comparison between Fibulin-4+/+ and
Fibulin-4R/R lungs (374 genes) were compared to this list of
COPD-related genes derived from IPA, where we found an
overlap of 6 genes: PDE3B (1.28 q), HCK (1.55q), PRF1 (1.47
q), SERPINA1 (1.38 Q), FGFR3 (1.28 Q), and EFEMP2 (i.e.
Fibulin-4, 3.57 Q). In a second analysis, we compared the 374
deregulated mouse genes to a list of 125 deregulated genes from
the comparison of GEO dataset GSE8581 (1.5-fold, FDR 30%),
consisting of 15 COPD cases (predicted FEV1,70%, FEV1/
FVC,0.7) and 18 control cases (predicted FEV1.80%, FEV1/
FVC.0.7). This comparison showed an overlap of ITPKC (1.28
Q), KIAA1377 (1.45Q), and SERPINA1 (1.38Q). Remarkably,
these two independent methods both identified SERPINA1 as an
overlapping downregulated gene. SERPINA1 encodes for the
serine protease inhibitor a-1 antitrypsin, whose targets include
elastase. Interestingly, deficiency in a-1 antitrypsin in patients is
associated with lung emphysema [22,23].
In the mouse lung mRNA gene expression analysis SERPINA1
was significantly downregulated in both Fibulin-4R/R lungs (1.38-
fold, p,0.01) as well as in Fibulin-4+/R lungs (1.59-fold, p,0.01)
compared to Fibulin-4+/+ lungs. We used Path explorer in IPA
that identifies pathways between differentially expressed genes, in
order to determine the relation between Fibulin-4 and SER-
Table 2. The most significantly up-regulated genes in adult Fibulin-4R/R lungs. Genes are indicated with their ratios compared to
Fibulin-4+/+ lungs and the process involved.
Top up-regulated genes
Genes Ratio Function
Arg1 3.68 Urea cycle
Slpi 3.37 Inhibitor serine proteases
Ms4a4b 2.38 T-cell regulation
Wisp2 2.26 Inhibits proliferation of vascular smooth muscle cells
Prkcb 2.03 B-cell activation, apoptosis
Emr4 1.98 Mediate between myeloid- and B-cells
Cd300a 1.92 Leukocyte cell surface proteins
Gzma 1.93 Cytotoxic T-cell and natural killer cell specific serine proteases
Klra4 1.91 Natural killer cell receptor
Nkg7 1.90 Natural killer cell granule protein
Ctsw 1.84 Regulation of T-cell cytolytic activity
Wisp1 1.83 Matrix remodeling
Lrat 1.64 Retinoid cycle
Plac8 1.81 Defense response to bacterium
Ccl5 1.78 Chemotactic cytokine and plays active role in recruiting leukocytes
Tspan32 1.73 Tumor suppressing fragment
Cyp51a1 1.70 Production of sterols
Rbm3 1.68 Temperature induced
Bcl2 1.66 Apoptosis regulator
Mef2c 1.65 Transcription factor important for vascular development
doi:10.1371/journal.pone.0106054.t002
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Figure 4. Increased inflammation in Fibulin-4R/R lungs compared to Fibulin-4+/+ and Fibulin-4+/R lungs. (A) Flow cytometric analysis
revealed more Gr1+ granulocytes and CD19+ B-cells in BAL samples from Fibulin-4R/R (n = 4) compared to Fibulin-4+/+ mice (n = 4, *p,0.05) and (B)
increased numbers of F4/80 macrophages in Fibulin-4R/R lungs (n = 4, *p,0.05). (C) HE stained sections from adult (n = 4, n = 4, n = 4) Fibulin-4+/+,
Fibulin-4+/R and Fibulin-4R/R lungs showing focal infiltrations around vessels and airways in Fibulin-4R/R lungs (black arrows). (D) Staining for T-cells
(CD3+) and (E) dendritic cells (CD11c+) points to the presence of inflammatory cells within the focal infiltrations. Magnification 20x. Scale bar 50 mm.
(F) ELISA analysis showing increased IL-1b levels in Fibulin-4R/R lungs (n = 4, *p,0.05).
doi:10.1371/journal.pone.0106054.g004
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PINA1. By calculating the shortest path between Fibulin-4
(EFEMP2) and SERPINA1, an indirect connection of Fibulin-4
to MMP9 and a direct connection of MMP9 to SERPINA1 was
revealed, as indicated by the black arrows in Figure 5D
[14,24,25]. Surprisingly, by connecting Fibulin-4, MMP9 and
SERPINA1 (both direct and indirect) to the significantly
Figure 5. Increased TGF-b signaling in Fibulin-4+/R and Fibulin-4R/R lungs. Immunoblot analysis of pSmad2 in lung homogenates shows an
increase in the amount of pSmad2 (A) and pSmad3 (B) in Fibulin-4+/R (n = 3) and Fibulin-4R/R (n = 3) lungs, compared to the total amount of Smad, and
to their Fibulin-4+/+ control (n = 3). (C) Increased pSmad2 staining of inflammatory and endogenous cells on Fibulin-4+/R (n = 3) and Fibulin-4R/R (n = 3)
lung sections. Magnification 2.5x (scale bar 1 mm) upper panel and 20x (scale bar 200 mm) lower panel. (D) Ingenuity pathway explorer showed
MMP9 as the shortest connection between Fibulin-4 and SERPINA1. SERPINA1 inhibits neutrophil elastase, which affects elastin. MMP9 itself was not
deregulated in Fibulin-4R/R lungs (n = 4), but could be connected to 16 deregulated genes in Fibulin-4R/R compared to Fibulin-4+/+ lungs (n = 4, red,
up-regulated; green, downregulated), suggestion altered MMP9 activity. Black arrows indicate the connection between Fibulin-4 (EFEMP2), MMP9,
SERPINA1, elastase and ELN. Grey arrows indicate the connection of these genes with deregulated genes between Fibulin-4+/+ and Fibulin-4R/R lungs.
doi:10.1371/journal.pone.0106054.g005
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deregulated genes identified in the SAM comparison between
Fibulin-4+/+ and Fibulin-4R/R lungs (grey arrows), we found an
interaction between 16 of those significantly deregulated genes and
our dataset with MMP9 (Figure 5C). Importantly, MMPs are
proteins involved in remodeling of the ECM, and play a role in
aneurysm formation. As we hypothesized that ECM defects
provide the link between the relation between AA and COPD,
MMPs could very well be part of the underlying mechanism. Since
our gene expression analysis did not show a deregulation of
MMP9 at the mRNA level, yet the pathway analysis pointed
towards involvement of MMP9, we next investigated MMP9
protein activity in Fibulin-4R/R and Fibulin-4+/R lungs.
Increased MMP and neutrophil elastase activity in
Fibulin-4 deficient lungs. Fluorescent imaging using protease
activatable probes showed increased pulmonary MMP activity in
adult Fibulin-4 deficient mice (Figure 6A). The observed decrease
in the elastase inhibitor SERPINA1 and the increased MMP
activity, which is also associated with cleavage of a-1 antitrypsin
[24], might lead to increased activity of neutrophil elastase (NE)
(also see Figure 5C for this relation). Indeed, we observed a graded
increase in NE activity in adult Fibulin-4+/R and Fibulin-4R/R
lungs compared to Fibulin-4+/+ lungs (Figures 6B and C). In line
with this, pulmonary elastin staining demonstrated interruptions in
the elastin layers in Fibulin-4+/R lungs and even more in Fibulin-
4R/R lungs compared to those of Fibulin-4+/+ animals (Figure 6D),
as previously found in the aortas of these mice [14]. Newborn
Fibulin-4R/R lungs also displayed elastin abnormalities, while
newborn Fibulin-4+/R lungs were comparable to those of Fibulin-
4+/+ mice (data not shown).
Increased and prolonged inflammatory response in
lipopolysaccharide (LPS) exposed Fibulin-4+/R
mice. Fibulin-4+/R mice developed alveolar airspace enlarge-
ment with age together with increased MMP9 and NE activity in
the absence of inflammation. However, when adult Fibulin-4+/R
lungs were triggered by LPS administration, which mimics
bacterial infection in mice by initiating the infiltration of
inflammatory cells into the pulmonary alveoli similar to patients
with COPD exacerbation [26,27], flow cytometric analyses of
BAL samples and pulmonary cell suspensions showed an increased
and prolonged inflammatory response as compared to Fibulin-4+/
+ mice. There was a significantly greater influx of macrophages
(F4/80+) in the lungs 18 hours after LPS exposure and
significantly higher numbers of dendritic cells (CD11c+), T-cells
(CD3+), and granulocytes (GR1+) 72 hours after LPS exposure
(Figure 7 and Figure S3). Moreover, opposite dynamics were
observed; in the Fibulin-4+/+ lungs the amount of GR1+ cells
decreased after 18 hours, while an increase was observed in
Fibulin-4+/R lungs 72 hours after LPS exposure. The increase of
inflammatory cells after LPS exposure was significantly higher
when compared to PBS. The levels of pro-inflammatory cytokines
released upon LPS exposure, including IL-1b, TNF-a, and
keratinocyte-derived chemokine, were not different between
groups (data not shown). These data indicate that Fibulin-4+/R
mice exhibit an intensified inflammatory response in the lungs.
Discussion
In this study we show that COPD is more common in patients
with AA than in patients with atherosclerotic arterial disease. This
relationship was independent of cigarette smoking and other
known risk factors. Furthermore, there was no difference in serum
hs-CRP levels between patients with and without COPD,
indicating that inflammation per se is unlikely to account for the
observed relation between COPD and AA. The findings in this
large patient cohort are in line with previous observations of
reduced respiratory function in smaller series of AAA patients
[6,7,10]. Although some previous studies concluded that the
association between COPD and aneurysm formation was related
to smoking, medication use or presence of other cardiovascular
risk factors, these associations became non-significant after
correction in multivariable analyses. [28,29]. Our findings suggest
that factors other than cardiovascular risk profiles or systemic
inflammation contribute to the association between COPD and
AA.
Since both diseases, COPD and AA, are characterized by
breakdown of the ECM in the airways and –spaces and in the
aortic wall, we investigated whether a primary ECM defect
provides the pathogenic link between these two diseases.
Analogous to the observed degradation of the aortic wall, up-
regulation of MMP activity both thoracic as well as abdominal,
and previously observed formation of AAs in mice deficient in the
ECM component Fibulin-4, we found that gradual downregula-
tion of Fibulin-4 in the lungs correlated with destruction of
alveolar walls and airspace enlargement that is characteristic for
lung emphysema. Similar to embryonically lethal, complete
Fibulin-4 knockout mice [16], alveolar breakdown was already
present in lungs of newborn Fibulin-4R/R mice, and became
progressive with age. In contrast, Fibulin-4+/R mice, which have
only a 2-fold reduction in the amount of Fibulin-4, had normal
elastin structures and alveolar airspaces at birth, but acquired
alveolar breakdown with ageing.
Analogous to the activation of the TGF-b pathway in the aortas
of Fibulin-4 deficient mice [14], we here demonstrate enhanced
activation of the TGF-b pathway in the lungs of Fibulin-4+/R and
Fibulin-4R/R mice. The co-occurrence of lung emphysema and
vascular abnormalities in association with deregulated TGF-b
signaling has also been shown in another mouse model with a
deficiency in an ECM protein, Fibrillin-1, which is a model for
Marfan syndrome [30]. Moreover, the combination of pulmonary
emphysema and aortic aneurysms coinciding with upregulation of
TGF-b signaling has also been observed in autosomal recessive
cutis laxa syndrome caused by Fibulin-4 mutations [31–33]. The
role for TGF-b in this process is further supported by the
development of progressive airspace enlargement in Smad3
knockout mice, which are deficient for an intracellular regulator
of the TGF-b pathway [34]. Overall, these data point to
deregulated TGF-b signaling and ECM defects as common
underlying factors for aortic and pulmonary abnormalities.
Expression analysis further revealed downregulation of the
SERPINA1 gene, encoding for the serine protease inhibitor a-1
antitrypsin whose targets include elastase. Interestingly, overlap-
ping gene expression profiles of our Fibulin-4 deficient mice with
those of COPD patients revealed downregulation of SERPINA1
as a common denominator. As it is known that patients with a-1
antitrypsin deficiency develop COPD [22,35] we explored the link
between SERPINA1 and Fibulin-4. Pathway exploration in IPA
revealed a direct link to MMP9, TGF-b deregulation and 15 other
deregulated genes from our dataset. Although MMP9 itself was
not overexpressed, molecular imaging showed that the MMP
activity was gradually higher in Fibulin-4+/R and Fibulin-4R/R
lungs. In line with the observed downregulation of SERPINA1,
fluorescent imaging showed a gradual up-regulation of elastase in
Fibulin-4+/R and Fibulin-4R/R lungs, which correlated with elastin
fragmentation. The decreased expression of SERPINA1 may
either be a direct effect of Fibulin-4 deficiency, or an indirect effect
through its cleavage by MMP9[24]. This combination of increased
protease activity and decreased antiprotease activity may account
for the breakdown of alveolar walls, resulting in emphysema.
Extracellular Matrix Defects Cause Aortic Aneurysms and COPD
PLOS ONE | www.plosone.org 9 September 2014 | Volume 9 | Issue 9 | e106054
Another hallmark of adult Fibulin-4 mice was the inflammatory
response in the lungs. Lungs of adult Fibulin-4R/R mice already
displayed pulmonary inflammation in a specific pathogen free
environment, including influx of a wide range of inflammatory
cells with elevated levels of the pro-inflammatory cytokine IL-1b,
which coincided with the overexpression of genes involved in
inflammatory pathways. In contrast, adult Fibulin-4+/R animals
did not exhibit pulmonary inflammation under baseline condi-
tions, but displayed an enhanced respiratory inflammatory
response upon LPS inhalation. These findings indicate that
although inflammation may contribute to the progressive break-
down of alveolar walls in adult Fibulin-4R/R mice, it is unlikely to
be the primary causative factor in Fibulin-4+/R mice. Conversely,
ECM degradation by proteases is known to induce the release of
Figure 6. Higher MMP and NE activity in Fibulin-4+/R and Fibulin-4R/R lungs. In (A) and (C) ex vivo imaging of excised lungs using Odyssey
shows increased activity of MMP and NE respectively in Fibulin-4+/R (n = 7) and Fibulin-4R/R lungs (observed for n = 5, but two animals died during the
procedure) as compared to Fibulin-4+/+ lungs (n = 5), with a significant upregulation for Fibulin-4R/R lungs (**p,0.01). (B) Open-chest registration of
NE activity with Neutrophil Elastase FAST 680 probes shows increased activity in Fibulin-4+/R and Fibulin-4R/R lungs as compared to Fibulin-4+/+ lungs.
(D) Elastin staining of Fibulin-4+/+, Fibulin-4+/R and Fibulin-4R/R lungs (n = 3, n = 3, n = 3) shows fragmented elastin layers in Fibulin-4+/R and Fibulin-4R/R
lungs, indicated by arrows. Magnification 40x. Scale bar 10 mm.
doi:10.1371/journal.pone.0106054.g006
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bioactive fragments that may act as chemo-attractants for
leukocytes and modulate the activity of resident immune cells
[36]. Our data suggest that a mild Fibulin-4 deficiency induces
disruption of the ECM, which subsequently predisposes to an
enhanced inflammatory response with further breakdown of
alveolar walls. This vicious circle is further exacerbated by the
diminished antiprotease capacity of the lungs and ultimately results
in the development of pulmonary emphysema. The Fibulin-4R/R
mouse can therefore provide as a model for adverse lung
development, while the heterozygous Fibulin-4+/R mouse may
serve as a postnatal challenge model.
The traditional inflammatory model of COPD proposes that in
susceptible patients cigarette smoking leads to inflammation,
which subsequently induces loss of ECM and alveoli, resulting in
airspace enlargement. We propose that genetic ECM defects are
one of the initiating events contributing to this susceptibility, which
are associated with a heightened inflammatory response to
environmental triggers, such as microorganisms and smoking.
Such a generalized genetic susceptibility to ECM degradation and
secondary inflammation in combination with increased protease
activity and decreased anti-protease activity might be the common
pathophysiologic mechanism underlying the tissue destruction in
both COPD and aneurysm formation. Genetic screening for
mutations related to ECM defects may be a new strategy to




Patients. Consecutive patients undergoing elective open or
endovascular surgery for aortic aneurysm, peripheral arterial
disease, or carotid artery disease between 2002 and 2011 in the
Erasmus MC, Rotterdam, were included. Patients with an aortic
aneurysm (AA) were classified as aneurysmal disease. Patients with
atherosclerotic peripheral arterial or carotid artery disease were
classified as arterial occlusive disease (AOD). Patients treated with
combined AA and symptomatic AOD, and patients with a genetic
aneurysm syndrome like Marfan, Loeys-Dietz or vascular Ehlers-
Danlos syndrome were excluded. The study complies with the
declaration of Helsinki and was approved by the Institutional
Review Board of the Erasmus Medical Center (permit number
MEC-2011-510) in accordance with national and international
guidelines. Our institutional review board waived the need for
written informed consent from the participants since the data was
obtained for clinical purpose, there was no intervention and there
was a retrospective study design. Patient data were de-identified
prior to analysis.
Clinical characteristics. Medical history was obtained from
every patient, including the cardiovascular risk factors age, gender,
body mass index (BMI), smoking status, hypertension (blood
pressure $140/90 mmHg in non-diabetics, $130/80 mmHg in
diabetics, or use of antihypertensive medication), hypercholester-
olemia (low-density lipoprotein [LDL] cholesterol $3.5 mmol/L
or use of lipid lowering medication), diabetes mellitus (fasting
plasma glucose $7.0 mmol/L, non-fasting glucose $11.1 mmol/
L, or use of anti-diabetic medication), and kidney disease (serum
creatinine $2.0 mg/dl). Cardiovascular comorbidities were re-
corded, including congestive heart failure (defined as history of
congestive heart failure), ischemic heart disease (defined as a
history of angina pectoris, myocardial infarction, coronary
revascularization, or presence of pathologic Q-waves on the
electrocardiogram), cerebrovascular disease (defined as a history of
ischemic/hemorrhagic stroke or transient ischemic attack). Pre-
scription medications were recorded and included the use of
statins, beta-blockers, renin-angiotensin system inhibitors, diuret-
ics, and antiplatelet drugs. Serum concentrations of the inflam-
matory biomarker high-sensitivity C-reactive protein (hs-CRP)
were measured prior to surgery using immunochemistry (Beckman
Coulter, Woerden, the Netherlands).
Chronic obstructive pulmonary disease. The diagnosis
and classification of COPD was made using spirometry, which was
part of the routine preoperative workup and was obtained in 92%
of COPD patients. COPD was defined as the presence of a forced
expiratory volume in one second (FEV1) to forced vital capacity
(FVC) ratio (FEV1/FVC) ,0.70. In the presence of a FEV1/FVC
ratio of ,0.70, mild COPD was defined as a FEV1.80% of the
predicted FEV1 (GOLDI), moderate COPD was defined as a
Figure 7. Increased and prolonged inflammatory response in
LPS exposed Fibulin-4+/R mice. Quantification of immune cells
shows significantly increased F4/80+ cells after 18 hours of LPS
exposure in Fibulin-4+/R lungs (n = 4) and a significantly higher number
of Gr1+, CD11c+, and CD3+ cells after 72 hours of LPS exposure as
compared to Fibulin-4+/+ lungs (n = 4, *p,0.05).
doi:10.1371/journal.pone.0106054.g007
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FEV1 of 50–80% of the predicted FEV1 (GOLDII), and severe
COPD was defined as a FEV1,50% of the predicted FEV1
(GOLDIII/IV)[37]. Patients without spirometry were classified
based on the presence of pulmonary symptoms (i.e. cough,
dyspnea, sputum) and the use of pulmonary medication.
Statistical analysis. Dichotomous data are presented as
numbers and percentages. Continuous variables are presented as
mean 6 standard deviation or median and IQR when not
normally distributed. Categorical data were analyzed with chi-
square tests and continuous variables with ANOVA or Kruskal-
Wallis tests. Multivariable binary logistic regression analysis was
used to calculate odds for having COPD between AA and AOD.
Adjustments were made for age, gender, BMI, congestive heart
failure, ischemic heart disease, cerebrovascular disease, kidney
disease, diabetes mellitus, hypertension, hypercholesterolemia,
smoking, statins, beta-blockers, renin-angiotensin system inhibi-
tors, diuretics, antiplatelets, and hs-CRP. Furthermore, we
performed a propensity score to adjust for the possibility of
receiving a pulmonary function test prior to surgery. Covariates
were chosen on the bases of biological plausibility. For all tests, a
p-value ,0.05 (two-sided) was considered significant. All analyses
were performed using IBM SPSS Statistics version 20.0 (SPSS
Inc., Chicago, IL, USA).
Experimental study
Animals. Fibulin-4 animals were generated as previously
described [14]. All mice used were bred in a C57BI/6J
background and were kept in individually ventilated cages to
keep animals consistently micro-flora and disease free. To avoid
stress-related vascular injury, mice were earmarked and genotyped
4 weeks after birth. Mice used were either newborn or adult
(110610 days). Adult mice were challenged by a single intratra-
cheal injection with either 80 ml ultra-pure, sterile Lipopolysac-
charide (LPS) 1 mg/ml from E. coli Serotype R515 (Alexis
Corporation Switzerland) or 80 ml PBS (Lonza). Animals were
housed at the Animal Resource Centre (Erasmus University
Medical Centre), which operates in compliance with the ‘‘Animal
Welfare Act’’ of the Dutch government, using the ‘‘Guide for the
Care and Use of Laboratory Animals’’ as its standard. As required
by Dutch law, formal permission to generate and use genetically
modified animals was obtained from the responsible local and
national authorities. An independent Animal Ethics Committee of
the Erasmus Medical Center (Stichting DEC Consult) approved
these studies (permit number 139-10-12 and 139-12-02), in
accordance with national and international guidelines.
Quantitative real time PCR. RNA was isolated using the
RNeasy minikit from Qiagen according to the provided protocol
and synthesized to cDNA with the RevertAid H Minus First
Strand cDNA Synthesis Kit according to the provided instruc-
tions. Quantitative Real-Time PCR was performed using Maxima
SYBR Green qPCR Master Mix 2x (Fermentas) also according to
the provided protocol. Reactions were performed in triplicates per
gene for each sample. The primers used for Fibulin-4, Gapdh and
Hprt (Invitrogen) are indicated in Table S7. Product specificity
was determined by melting curve analysis and gel electrophoresis.
The average Ct values of the triple reactions were calculated for
each gene according to cell type. The relative gene expression level
was calculated by the following formula for each gene:
Relative gene expression level = 2(Ct control–Ct sample) gene/2(Ct
control–Ct sample) housekeeping gene.
The levels of fold-change for each gene were calculated by
dividing the relative gene expression levels in Fibulin-4+/R or
Fibulin-4R/R lungs to the relative gene expression levels in wild
type lungs.
Whole body plethysmography. Conscious mice were
placed in a single-chamber, whole body, plethysmograph (Emka
Technologies, Paris, France) as described previously [38]. After an
adaptation period of 9 minutes (acclimatization), Peak Inspiration
Flow (PIF) and Peak Expiration Flow (PEF) were measured in 6
time blocks of 3 minutes. Differences in PIF and PEF indicate
differences in inspiration and expiration strength.
Lung morphometry. A random selection of images of HE
stained alveoli were obtained with the Leica DFC280DFC480
(Aristoplan) with a magnification of 10x. Large airways and vessels
were generally avoided. Next, alveolar airspace size quantification
was performed according to the fully automated D2 method as
described in Jacob RE et. al, where it was compared to the semi-
automated mean linear intercept measurements, and turned out to
be more sensitive and specific for subtle airspace enlargement
expected to be found in mild or early stage emphysema [39]. All
images were converted to grayscale before performing the analysis.
Fuzzy-c-means clustering with simultaneous correction of potential
luminance inhomogeneity was applied to each image for pre-
segmenting it into two classes: the foreground and the background.
The final segmentation was obtained by the graph-cut method
with the energies given by the class membership functions
calculated on the previous step. The resulting foreground was
split into separate compartments corresponding to the connected
components belonging to this class; see Figure S1 and the
accompanying legend for an illustration. Vector of the compart-
ment sizes obtained in such a way was converted from pixels to
micrometers. For each of the vectors we calculated the D2 measure
[33], an index based on the equivalent diameters of airspaces and
by incorporating higher moment factors from the airspace
diameter distributions, where enlarged airspaces are weighed
more heavily. This measure is useful to detect early or mild
emphysema. The compartments whose sizes were less than
138 mm were disregarded according to the threshold previously
reported in [39].
Histological analysis and immunohistochemistry. For
the lung morphometry procedure, mice were euthanized with a
lethal dose of pentobarbital (60 mg/ml, 0.1–1.5 ml per mouse
according to weight). Lung lobes were excised and the left lobe was
pressure fixed through the bronchi at a pressure of 25 cm H2O
with 4% paraformaldehyde (PFA), and fixed overnight at 4uC
before paraffin embedding. Lungs from newborn mice were
immersion fixed. The 5-mm sections were prepared from the
paraffin embedded lungs and put on Superfrost Ultra plus slides
(Menzel-Glaser). For the morphometric analysis paraffin sections
of the lungs were stained with Haematoxylin-Eosin (HE).
For histological analysis 100-day-old female mice were dissect-
ed. Mice were euthanized by CO2-inhalation. After opening
thorax and abdomen, mice were fixed by perfusion fixation
through the left ventricle, with PBS and 4% paraformaldehyde
(PFA). Organ weights were determined and macroscopic abnor-
malities noted. Organs and tissues were fixed in 4% PFA. Lungs
and aortas were dehydrated through the histokinette processor
(Microm), and paraffin embedded, after which 5-mm sections were
prepared.
Lungs and aortas were stained with HE for general pathology
and Resorcin-Fuchsin (Elastin von Gieson) for elastin structure.
For immunohistochemical analyses, sections were emerged in 3%
H2O2 in PBS to inhibit endogenous peroxidase. Antigen retrieval
was performed by boiling slides in 10 mM citrate buffer, pH 6.0,
at 600 W for 15 minutes in a microwave for TTF-1 and CC10
staining, 100 mM Tris 10 mM EDTA buffer, pH 9.0, at 300 W
for 20 minutes for pSmad-2 staining, or with pronase treatment
for a-SMA. Slides were first blocked in 5% Bovine Serum
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Albumin (BSA) in PBS and 0.5% Tween (and 5% Protifar in PBS
and 0.025% Triton X-100 for pSmad-2), and incubated with the
primary antibodies overnight at 4uC; TTF-1 (1:250 mouse
monoclonal Ab-1 Clone 8G7G3/1 Thermo Fisher Scientific),
CC10 (1:100 goat Ab (T-18): sc-9772 Santa Cruz Biotechnology),
Anti-Human Smooth Muscle Actin (1:250 mouse, clone 1A4
Biogenex Laboratories Inc.), and pSmad-2 (1:100 monoclonal
Rabbit anti-pSmad2 (S465|467 (138D4) Cell Signaling). The next
day slides were incubated with Horse Radish Peroxidase (HRP)
labelled secondary antibodies (1:100 DAKO) and avidin-biotiny-
lated secondary antibodies (Vectastain Universal Elite ABC kit
Vector Laboratories) for pSmad-2. DAB chromogen (DAKO
Liquid Dab substrate-chromogen system) was used as substrate
and slides were counterstained with haematoxylin.
Immunohistochemical stainings for inflammatory cells were
performed in a half-automatic stainer (Sequenza, Amsterdam, the
Netherlands). Acetone-fixed slides were blocked in diluted normal
goat serum (CLB, Amsterdam, the Netherlands) and stained
against mouse CD3 (1:10 rat monoclonal antibodies KT3 AbD
Serotec) and against mouse CD11c (1:20 hamster antibodies N418
Ebioscience). Primary antibodies were revealed by incubation with
diluted appropriate secondary antibodies coupled to alkaline
phosphatase for 30 min. Slides were subsequently incubated with
New Fuchsin substrate for alkaline phosphatase conjugates.
Finally, the sections were counterstained with Gills triple-strength
haematoxylin and mounted in VectaMount (Brunschwig, Am-
sterdam).
Micro-array hybridizations. RNA was isolated using the
RNeasy minikit from Qiagen with the provided protocol and
delivered to the department of Biomics, Erasmus MC. Synthesis of
double stranded cDNA and biotin labelled cRNA was performed
according to the instructions of the manufacturer (Affymetrix).
Fragmented cRNA was hybridized to Mouse Genome 430 V2.0
arrays, using a hybridization Oven 640 (Affymetrix), washed and
subsequently scanned on a GeneChip Scanner 3000 (Affymetrix).
To examine the quality of the various arrays, several bioinformatic
R packages (including affyQCreport and affyPLM) were run
starting from the raw CEL data files. All created plots, including
RNA degradation, RLE and NUSE plots indicated a high quality
of all samples and an overall comparability, except for one sample
(Fibulin-4R/R newborn lung), which was excluded from further
analysis. Raw intensity values of all samples were normalized by
robust multichip analysis normalization (background correction
and quantile normalization) using Partek version 6.4 (Partek Inc.,
St. Louis, MO). The normalized data file was transposed and
imported into OmniViz version 6.0.1 (Biowisdom, Ltd., Cam-
bridge, UK) for further analysis. For each probe set, the geometric
mean of the hybridization intensities of all samples was calculated.
The level of expression of each probe set was determined relative
to this geometric mean and 2log transformed. The geometric mean
of the hybridization signal of all samples was used to ascribe equal
weight to gene expression levels with similar relative distances to
the geometric mean. Differentially expressed genes were identified
using ANOVA (Partek) and SAM (Omniviz). The cut-off value for
significantly expressed genes was FDR 10% for adult Fibulin-4R/R
lungs compared to Fibulin-4+/+ lungs. Functional and network
analysis was done using Ingenuity Pathway Analysis (IPA;
Ingenuity Systems, www.ingenuity.com, Mountain View, CA).
Ingenuity pathway analysis is a web-based software application
that enables to analyze and integrate data derived from gene
expression microarrays into biological networks and pathways. All
Ingenuity products leverage the Ingenuity Knowledge Base, which
houses biological and chemical relationships extracted from the
scientific literature.
Significantly expressed genes from the adult Fibulin-4R/R to
Fibulin-4+/+ lungs comparison were compared to COPD-associ-
ated genes in Ingenuity and a list of literature based genes
associated with COPD. CEL files from GEO dataset GSE8581
were obtained and were analyzed following the above described
procedures. The GEO dataset GSE8581 consisted of 15 COPD
cases, with a predicted FEV1,70% and FEV1/FVC,0.7, and 18
control cases, with a predicted FEV1.80% and FEV1/FVC.0.7.
Subjects were undergoing surgical resection of a suspected lung
tumor and tissue for this dataset was derived from histologically
normal lung tissue distant from the tumor margin [40]. Cut-off
values for significantly expressed genes were FDR 30% and 1.5-
fold. Comparison to significantly expressed genes from the adult
Fibulin-4R/R to Fibulin-4+/+ lungs comparison was done using
IPA.
Preparation of cell suspensions, flow cytometry and
ELISA. Broncho Alveolar Lavage (BAL) was performed with 3
times 1 ml of Ca2+- and Mg2+-free PBS, containing 10 mM
EDTA. Furthermore, lungs were enzymatically digested using
collagenase type III (Worthington) for 1 hour at 37uC, followed by
washing and filtering. Cell suspensions were stained with
antibodies specific for F4/80-Fitc, MHC class II-PE, CD11c-
PeTexasRed, CD3-PECy5, CD19-APCCy7, CD25-APC and
GR-1-PECy7 (Becton Dickinson or eBiosciences). Nonspecific
binding to Fc-receptors was blocked by incubation with 2.4G2
antibodies, and DAPI (Invitrogen) was used as life/dead marker.
Acquisitions were performed on an LSRII flow cytometer (Becton
Dickinson) and data were analyzed by FlowJo (Treestar, Costa
Mesa, CA) software. Supernatants of BAL fluid were stored for
ELISA. BAL fluid cytokines were measured by commercially
available specific ELISA systems for IL-6, KC, MCP-1, TARC,
IL-10, IL-12, IL-1b, TNF-a, IFN-gamma and IL-17 according to
the manufacturers’ instructions. In a separate set of experiments,
flow cytometric analyses of BAL samples and pulmonary cell
suspensions were performed 18 or 72 hours after a single
intratracheal injection with either sterile lipopolysaccharide (LPS)
1 mg/ml in PBS or PBS alone in adult (100-days-old) Fibulin-4+/R
and Fibulin-4+/+ mice.
Western blot analysis. Western blot analysis was performed
as described before [41]. In short, equal amounts of lung tissue
homogenates (40 ug) were separated under reducing conditions on
10% SDS-PAGE. Proteins were transferred to nitrocellulose
membranes (Whatman, Germany) and blocked with 5% milk.
After washing, membranes were incubated with rabbit anti-
phosphorylated Smad2 (Cell Signaling Technologies, USA) and
rabbit anti-phosphorylated Smad3, kindly provided by Dr. E.
Leof, Mayo Clinic, Rochester, MN, USA followed by HRP
labelled secondary antibodies (GE Healthcare) and detection with
a chemiluminiscent substrate (Pierce). Afterwards membranes
were stripped and reprobed with anti Smad2/3 antibodies (BD
biosciences), b-actin (Sigma) or GAPDH (Millipore) as a loading
control.
Fluorescence imaging. We used vascular fluorescent medi-
ated tomography (FMT) imaging with near-infrared fluorescent
protease activatable probes as previously described [15,42]. Open
chest FMT imaging of fibulin-4 mice was performed using an
FMT 2500 system (Perkin Elmer Inc.) at 680- and 750-nm
excitation and emission wavelengths, respectively, at five hours
after tail vein injection of 4 nmol of Neutrophil Elastase 680 FAST
and 2 nmol of MMPsense 750 FAST (Perkin Elmer Inc.). Mice
with open chests were fixed into the portable animal imaging
cassette that lightly compressed the mouse between optically
translucent windows. The FMT 2500 quantitative tomography
software was then used to calculate 3D fluorochrome concentra-
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tion distribution of Neutrophil Elastase 680 FAST and MMPsense
750 FAST.
After open chest fluorescence imaging, complete lungs were
harvested and fluorescence was quantified using the FMT 2500 or
Odyssey imaging systems (LI-COR Inc.). Near-infrared images
were obtained in the 680- and 700-nm channels, respectively.
Statistical analysis. Data are presented as mean 6 SEM.
Statistical analysis for lung morphometry was performed using the
Kolmogorov-Smirnov test. The Kruskal-Wallis one-way ANOVA
was used to determine any significant differences between groups.
The nonparametric Mann-Whitney U-test was performed to
analyze the specific sample pairs for significant differences. A p-
value of ,0.05 was considered to indicate a significant difference
between groups. All analyses were performed using IBM SPSS
Statistics version 20.0 (SPSS Inc., Chicago, IL, USA).
Supporting Information
Figure S1 Larger alveolar airspaces in newborn Fibulin-
4R/R lungs (A) and adult Fibulin-4+/R and Fibulin-4R/R
lungs (B). To quantify and compare the sizes of the alveolar
airspaces, the compartments from the different alveolar airspaces
were segmented on the HE images according to the method
described in the ‘‘Lung morphometry’’ section of the Material and
Methods section. Each segmented compartment was given a
different color as shown and subsequently quantified as described.
Magnification 10x. Scale bar 100 mm. (C, D) Comparison of the
architecture of the aortic wall in Fibulin-4+/+, Fibulin-4+/R, and
Fibulin-4R/R mice used for alveolar airspace analysis in Figure 3C.
Haematoxylin- eosin (HE) staining of cross-sections from 120 day-
old mice (C). Aberrations in elastic laminae in Fibulin-4R/R mice,
consisting of a fragmented and disorganized appearance of elastin
in the medial layers of the aorta (D).
(TIF)
Figure S2 Similar cell structures in wild type and
Fibulin-4 knockdown lungs. Stainings for (A) respiratory
epithelial cells with TTF-1, (B) Clara cells with CC10 and (C)
smooth muscle cells with a-SMA show similar cell structures in
Fibulin-4+/+ (n = 3), Fibulin-4+/R (n= 3) and Fibulin-4R/R (n= 2)
lungs. Magnification 10x. Scale bar 100 mm.
(TIF)
Figure S3 LPS infection induces infiltration of inflam-
matory cells in the alveolar compartments. Quantification
of immune cells in alveolar compartments shows increased CD3+
cells after 72 hours of LPS exposure in Fibulin-4+/R (n = 4) as
compared to Fibulin-4+/+ lungs (n = 4, *p,0.05).
(TIF)
Table S1 Clinical characteristics of patients with de-
scending thoracic aortic aneurysm (TAA) or abdominal
aortic aneurysm (AAA).
(DOCX)
Table S2 COPD in patients with descending thoracic
aortic aneurysm (TAA) or abdominal aortic aneurysm
(AAA).
(DOCX)
Table S3 Association between COPD and aneurysmal
disease.
(DOCX)
Table S4 The most significantly down-regulated genes
in lungs of adult Fibulin-4R/R mice.
(DOCX)
Table S5 Over-expressed canonical pathways, based on
IPA, in lungs of adult Fibulin-4R/R mice (p,0.05).
(DOCX)
Table S6 Deregulated TGF-b pathway genes in adult
and newborn Fibulin-4 deficient lungs compared to
Fibulin-4+/+ lungs (p,0.05).
(DOCX)
Table S7 Primers used for quantitative real time PCR.
Forward and reverse primers are displayed for each
gene from 59 to 39.
(DOCX)
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